Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis.
Antonio TundoSophia Betro'Rocco de FilippisFulvia MarchettiDaniele NaccaRoberta NecciMarica IommiPublished in: Life (Basel, Switzerland) (2023)
The findings of this systematic review, needing further confirmation, show that off-label use of pramipexole as augmentation of antidepressant treatment could be a useful and safe strategy for unipolar and bipolar treatment-resistant depression.